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Second messenger formation altered by different dialysis membranes in
human leukocytes. A number of agents stimulate transmembrane cell
signaling in different cell types through the formation of the second
messenger diacylglycerol (DAG) which activates protein kinase C (PKC).
The aim of this study was to investigate phospholipase C activation, DAG
formation, and cellular adhesion to dialysis membranes after simulated
dialytic treatment of either human leukocytes or clonal hematopoietic
cells. Cells were circulated for 60 minutes in a closed-loop dialysis system
using three different dialyzers: cuprophan (CU), polysulphone (PS), and
AN69 (PAN). Another cell aliquot was left within the dialyzers without
circulation. Samples were taken at different time intervals and cells
counted. Cells were labeled with tritiated glycerol overnight, and DAG
was measured by thin-layer chromatography. Our data showed that cells
tended to adhere with more efficiency to CU than to the synthetic
dialyzers. Circulation in the in vitro dialysis circuit resulted in the rapid (5
mm) formation of [3H]DAG (CU 1.95-; PS 1.34-; PAN 1.24-fold increase
over untreated cells). The DAG level peaked at 15 to 30 minutes and
remained constant thereafter (CU 1.70; PS 1.96; PAN 1.66). When we
measured DAG formation in cells that had been kept in the dialyzers
without circulation, we found that cells exposed to CU showed a much
higher and rapid activation than those exposed toPS or PAN, as if CU per
Se was able to activate early cell signaling (CU 1.95-; PS 0.97-; PAN 1.09-;
DAG, -fold increase over control). These data indicate that exposure to,
and circulation through dialyzers activated early transmembrane signaling
in human leukocytes, and that different dialysis membranes showed
distinct effects on cell adhesion and stimulation.
Dialysis hiocompatibility involves a broad spectrum of effects
that occurs during the interaction between patient's blood and
extracorporeal circuit, as it has been recently and extensively
reviewed [1].
We have addressed this issue from a new point of view and for
the first time to our knowledge, we have investigated the trans-
membrane signaling mechanisms either in patients undergoing
dialysis, or in simplified experimental models.
Activation of the phospholipase C, leading to the formation of
calcium-mobilizing inositol 1,4,5-trisphosphate (1P3) and 1,2-
diacylglycerol (DAG), which activates protein kinase C (PKC), is
considered a major event in signal transduction (Fig. 1).
Profound modifications of the transmembrane signaling ma-
chinery have been found to be the cause of most —if not all—
pathological states examined. 2, 3, 4].
The aim of the present study was to investigate whether
exposure to different dialysis membranes altered cell activation as
monitored by DAG formation. The experimental approach to this
problem consisted in the study of phospholipase C activation,
DAG formation, and cellular adhesion to dialysis membranes
after simulated dialytic treatment of either human leukocytes or
clonal hematopoietic cell lines. Clonal myeloid cells were chosen
instead of human samples in order to minimize variability due to
inter-individual variations between donors. Following the in vitro
approach, agonist-induced second messenger formation were
studied in lympho-monocytes from patients before and after
dialysis.
This study clearly demonstrates that exposure to dialysis filters
activates early transmembrane signaling in human lympho-mono-
cytes and that different dialyzers show distinct effects on cell




32D myeloid immature murine hematopoietic cells (clone 3)
were cultured in the presence of their physiological growth factor,
interleukin-3 [5—7]. They were chosen because of their poor ability
to stick to the plastic material of cell culture plates; in fact, these
cells can be maintained and proliferate in suspension without
adhering.
Peripheral blood mononuclear cells (PBMC) were prepared by
centrifugation of heparinized blood from dialysis patients and of
buffy coat freshly obtained from volunteer blood donors, over
Lymphoprep (Nycomed AS, Oslo, Norway). Mononuclear cells
were collected from the interface and washed twice in RPMI 1640
medium containing 10 mtvi Hepes, 2 mvt glutamine and 10% fetal
calf serum (FCS, HyClone, Logan, Utah, USA).
Cell suspensions were incubated overnight at the concentration
of 1.5 >< 106-ml in RPMI 1640 medium in the absence, or in the
presence of LPS (Difco, Detroit) at final concentrations ranging
from S to 500 j.rg/ml.
In vitro recirculating system
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In these experiments three types of hollow fiber dialyzers were
used: (1) Cuprophan (CU) ElS with a wall thickness of 8 and a
surface of 0.6 m2 (Fresenius AG, Oberursel, Germany); (2)
Polysuiphone (PS) F-40 with a wall thickness of 40 j.r and a surface
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Fig. 1. Schematic diagram of the
phosphoinositide signaling system indicating the
events that follow the agonist stimulation of
receptors associated with the
phosphatidylinositol turnover. Abbreviations
are A, agonist; R, receptor; G, G-protein;
PLC, phospholipase C; Ptdlns,
phosphatidylinositol; DAG, Diacylglycerol;
PKC, protein kinase C; ER, endoplasmic
reticulum.
of 0.65 m2 (Fresenius AG); (3) AN69 (PAN) Filtral 6 with a wall
thickness of 50 and a surface of 0.60 m2 (Hospal Italia,
Mirandola, Italy). The system was rinsed with 2 liters of hepa-
rinized, isotonic, pyrogen-free saline, to remove both beta-glucans
eluting from CU and various substances eluting from the other
membranes. The dialysate compartment was tightly closed. Three
experiments were performed, each in triplicate samples, for every
tested filter, in static and circulating conditions. Each experiment
lasted 60 minutes.
In recirculation experiments the system was connected to the
reservoir, and about 200 ml of either buffy-coat or 32D cell
suspension containing approximatly 0.5 to 1 x 106 cells/mi were
set to recirculate. Flow was 100 mI/mm. Samples were drawn at 0,
5, 15, 30 and 60 minutes.
In no-flow conditions, cells were injected into the dialyzers
(after rinsing as previously described) and collected at the same
time intervals. Filters remained in a horizontal position upon a
table, closed at both ends throughout the experiment. Immedi-
ately before obtaining the samples, filters were gently rolled. The
first drawn aliquot of the cell suspension was discarded and a
second aliquot was used to test cellular response, so as to extract
random and homogenous samples. In recirculation and resting
experiments 32D cells were suspended in serum-free culture
medium, RPM! 1640 (PB!) without L-glutamine, in order to avoid
any interference from complement activation.
Patients
Five patients on chronic maintenance hemodialysis were se-
lected. Informed consent was obtained from each subject. The
mean age of the patients was 59 (range 32 to 68 years), with a
mean dialytic age of 2.5 years (range 1 to 6 years). Patients were
clinically free of inflammatory and neoplastic diseases. The pa-
tients were submitted to two dialytic sessions, the first with
cuprophan dialyzer, the second with polysulphone or AN69 filter.
The interval between these two studies was three weeks. The
dialysate routinely used contained bicarbonate (Na 139 mEq/liter,
K 2 mEq/liter, Ca 3.0 mEq/liter, HCO3 30 mEq/liter, acetate 5.0
mEq/liter). It was prepared from sterile concentrate bags. Endo-
toxin content in dialysate was measured 60 minutes after start of
the dialysis, using Limulus amebocyte lysate chromogenic bioas-
say (Kabi Vitrum, Sweden); minimum detectable levels were 10
pg/mi. Endotoxin contamination in dialysate was 35 14 pg/mI.
Blood flow in all patients was 300 ml/min. Blood samples were
drawn pre-dialysis and at the end of dialysis procedure.
Study of cellular response
Cellular adhesion to dialyzers was monitored as cell number
variations.
The level of second messengers (either at steady state, or
following stimulation) was determined in cells prelabeled to
equilibrium with [3H]inositol, [3H]glycerol, or [32P]ortho-phos-
phate, following labeling and serum-starvation procedures previ-
ously described [6, 7]. The turnover of inositol lipids was moni-
tored either as degradation of the labeled precursors (that is,
polyphosphoinositide breakdown) or as formation of breakdown
products (that is, labeled inositol phosphates, diacylglycerol,
phosphatidic acid). [3H- or 32P]labeled polyphosphoinositides
were separated and analyzed by thin-layer chromatography (TLC)
[8]. [3H]inositol phosphates were separated by ion-exchange
chromatography or by high-pressure liquid chromatography [6].
[3Hdiacylglycerol and [32P]phosphatidic acid were separated by
TLC [9].
Results of second messenger measurement were expressed as
fold variation in each analyzed metabolite over that without
treatment, that is, before challenging the cells with the mem-
branes (Figs. 3, 4), or without LPS stimulation (Fig. 5). In a typical
experiment a concentration of approximately 1 X 106 cells/mi was
used, and the incorporation of radioactive labeling was as follows;
diacylglycerol 19326 467; glycerol-containing phospholipids,
2644317 9598 (cpm SE,N = 7, of radioactivity associated with
diacylglycerol or phospholipids spots on TLC plate); inositol
phosphates, 3347 125; inositol-containing phospholipids, 33259
EI1IiiJ Cytokines, growth factors,
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1542 [cpm SE, N = 7, of radioactivity recovered in the total
inositol lipid fraction, and of an aliquot (100 p1) of the organic
phase of modified Folch extraction]; phosphatidic acid, 518 32;
total phospholipids, 4462 309 (cpm SE, N =5, of radioactivity
associated with phosphatidic acid or phospholipids spots on TLC
plates). In order to minimize error due to variability in cell
number, labeling procedure, and extraction efficiency, the ratios
diacylglycerol/phospholipids, inositol phosphates/phosphoinosi-
tides, were taken into account in making calculations. This
procedure of result normalization has proven reliable in a variety
of experimental conditions involving second messenger measure-
ment [2, 4, 6, 7, 9].
Statistical analysis
All data are given as mean SEM and compared by means of
the Student's I-test and ANOVA, when appropriate. P values less
than 0.05 were considered to be significant.
Results
Cellular adhesion to dialyzers
Figure 2 shows that in non-recirculation conditions 32D cells
Fig. 2. Adhesion of clonal hematopoietic cells
(32D) to polysulphone (A) and cuprophan (B)
dialyzers, during recirculation (• •) and in
no-flow conditions (•----•). AN69 showed the
same behaviour as polysulphone. Results are
expressed as variation in the cell number and
obtained from three experiments, each
performed in triplicate samples.
Fig. 3. Fonnation of diacyiglycerol in
human normal leukocytes during circulation
through cuprophan (A), polysuiphone (B) or
AN69 (C) dialyzers. Results are expressed
as the fold increase over control cells, and
represent 3 experiments, each performed in
triplicate samples. Results were normalized
for the total incorporation of radioactivity
in parent phospholipids as described in the
Methods section.
adhered promptly as evidence by a sharp decrease in the number
of collected cells after five minutes. When comparing different
membranes, it was quite evident that cells tended to adhere with
more efficiency to the natural material CU than to the synthetic
dialyzers.
Figure 2 evidences that approximately after 30 minutes of
circulation, the flow through the dialyzer detached the adherent
cells and, consequently, their number tended to increase. Differ-
ent materials gave qualitatively identical patterns of behavior,
even though the initial decrease in cell number was sharper with
CU (Fig. 2).
Metabolism of second messengers
The formation of DAG was measured, and the hydrolysis of
polyphosphoinositides in 32D cells and in human normal leuko-
cytes in contact with the inner surface of the dialyzers. Having
observed a difference in adhesion between no-flow conditions and
circulation through the filters, we wanted to study cellular activa-
tion also comparing DAG formation in non-recirculation condi-
tions and during circulation. Figure 3 shows that the different
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Fig. 4. Comparison of diacylglycerol formation in
non-recirculation conditions () and during
circulation (n). Samples were obtained at 30
minutes in order to obtain the greatest
comparable stimulation for the three tested
membranes. Values were derived from 3
experiments, each performed in triplicate
samples. Results are expressed as fold increase
over untreated cells. Results were normalized
for the total incorporation of radioactivity in
parent phospholipids as described in the
Methods section.
100 200 300 400 500
LPS, pg/mi
Fig. 5. Diacylglycerol formation induced by LPS in lympho -monocytes from
uremic patients obtained before (—) and after ( ) dialysis. All values
measured at the end of extracorporeal treatment were significantly lower
than those at the beginning (P < 0.001). Each point represents mean
values obtained from five patients. Results are expressed as the fold
increase over untreated cells. Results were normalized for the total
incorporation of radioactivity in parent phospholipids as described in the
Methods section.
the rapid metabolism of DAG, considered as an early indicator of
cellular activation. Notably, cuprophan caused the rapid and
sustained formation of DAG, thus indicating an intense stimula-
tion of cellular signaling. On the other hand, polysuiphone and
polyactylonitrile showed a delayed time course in the formation of
DAG, reaching the same levels as cuprophan only at 30 minutes
of recirculation through the system. It is worth noting that these
results, which were obtained in normal human leukocytes, were
also reproduced in the clonal hematopoietic cell line designed
32D that had been previously used to measure cellular adhesion.
Qualitatively identical results were obtained measuring either
inositol phosphate, phosphatidic acid formation, or polyphospho-
inositide breakdown (data not shown). The formation of DAG
occurring concomitantly with that of inositol phosphates and
phosphatidic acid indicates early activation of one of the phos-
pholipase C isozymes. Taken together, these results trace a
temporal relationship between cellular adhesion and activation.
Circulation through the filters caused a more marked activation of
cellular signaling—as evidenced by DAG formation—than in
no-flow conditions. However, with material that strongly activated
cellular signaling (such as cuprophan) this difference was less
evident: in fact, cuprophan stimulated the formation of DAG to a
similar extent both in non-recirculation conditions and during
circulation (Fig. 4). These experiments demonstrate that adhesion
and rolling through the filter caused rapid alterations of cellular
signaling and activation.
To extend these observations to the study of cell alteration
occurring during actual dialytic treatment, the second messenger
formation in lympho-monocytes of dialyzed patients immediately
before and after the dialysis was studied. We postulated that, if
cell adhesion and activation of signaling occurred during the
dialysis, with the resulting activation and down-regulation of PKC,
then, after the dialysis, the cells should not respond properly to
stimulation with an agonist known to activate phospholipase C.
LPS was used as agonist because this factor is believed to activate
cells independently of their receptorial asset, thus ruling out
errors due to inter-individual variations of cell surface receptors.
The results, shown in Figure 5, demonstrate that increasing
concentrations of LPS caused significant formation of DAG in
lympho-monocytes from uremic patients; this response was simi-
lar to that observed in cells from healthy donors (not shown), thus
indicating that renal disease per se did not significantly impair the
signal transduction machinery leading to DAG formation and
PKC activation. However, cells from the same subjects challenged
with increasing concentration of LPS after the dialysis failed to
respond, and no significant formation of DAG was observed (Fig.
5), independently of the type of membrane used.
Discussion
In this report, we describe polyphosphoinositide generation, a
marker of cellular activation, in leukocytes after contact with
cellulose and synthetic dialyzers. Cell adhesion to the filter
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occurred quite rapidly (5 mm), and, without circulation, was
sustained for at least one-half hour. In the presence of circulating
fluid, cells were slowly removed from the inner surface of dialyz-
ers. According to the literature [7], and to our experience with
hematopoietic cell types, adhesion and rolling through the filter
could be sufficient stimuli for cell activation with resulting forma-
tion of intracellular second messengers (Fig. 1). Actually we have
found that cells exposed to cuprophan show a more rapid
activation than those exposed to polysulphone or AN69, as if
cuprophan per se was able to activate early cell signaling, inde-
pendently of circulation in the dialysis system. In comparison with
cuprophan, polysulphone and AN69 induce a delayed and lower
cell stimulation. These results provide a molecular mechanism to
understand hemodialysis related phenomena.
Defects in the cellular immunity are well documented in
hemodialysis patients [1]. However, this immunodeficiency state
coexists with overexpression of IL-2Ra and IL-2Rf3 subunits,
markers of lymphocyte activation, in cuprophan treated patients
[10]. A reduced IL-2 production and decreased proliferation in
response to antigenic and mitogenic stimulation have also been
reported in hemodialysis patients [11, 12]. T lymphocytes activa-
tion involves generation of second messenger molecules (DAG,
calcium, etc.) [13, 14]. T cells are then down-regulated by specific
enzyme activity [151. Since we have demonstrated the activation of
the phosphoinositide signaling pathway in leukocytes after direct
interaction with the polysaccharide components of the cuprophan
membrane and, to a lesser extent, after exposure to synthetic
membranes, we suggest that the chronic stimulation in dialysis
patients may down-regulate the cellular ability to respond to
further antigenic or mitogenic stimuli [16, 17], giving reason for
the immunodeficiency documented in dialysis patients.
Enhanced susceptibility to infectious diseases which character-
izes end-stage renal disease has been referred to defective phago-
cytic ability of leukocytes [18—21]. These studies suggest that the
impaired phagocytosis is related to a major intracellular defect,
namely at the protein kinase C level or beyond, and that the
phagocytic response is further worsened by cuprophan and not
improved by dialysis with synthetic membranes [18]. It is possible
that the recurrent intradialytic leukocyte activation with subse-
quent "anergy" may be held responsible for the decrease of the
cellular response to further stimuli. The demonstration that
leukocyte response to Staph. A showed a marked suppression
after 15 minutes of cuprophan dialysis [18] is quite in keeping with
our observation of the early cellular activation after exposure to
cellulose dialyzer. The absence of such a decrease at minute 15
when non-complement activating membranes were used [221 may
well be explained by the different time course of DAG generation
with synthetic filters (Fig. 3). Thus, the resulting activation of
leukocytes induced by the dialyzer prevents them from coping
with further natural stimuli and may explain the enhanced sus-
ceptibility to infections in dialysis patients. To support the above
hypothesis, we have shown that, as a result of dialyzer induced
activation, patients' leukocytes were unable to respond to further
stimulation at the end of dialysis (Fig. 5).
It has been recently reported that hemodialysis-induced neu-
tropenia involves modulation of leukocyte adhesion molecules
[23—25]. Moreover, during cuprophan dialysis the up-regulation of
CD11b/CDI8 (MAC-i) and down-regulation of LAM-i leukocyte
adhesion molecules occur, reaching the full reciprocal change
after 15 minutes. These effects parallel the neutropenia clinically
observed. The modulation of the expression of these adhesion
receptors is mimicked in vitro by cell stimulation with C5a and
Phorbol myristate acetate, a direct activator of PKC [24]. In our
study with cuprophan dialyzer the time course of the intracellular
DAG formation, and subsequent PKC activation, parallel the
increased cell adhesion to the dialyzer and the time-related
modulation of LAM-i and CD11b/CDi8 expression. Alvarez et al
[231 observed no change on plasma membrane antigen expression
using polyacrylonitrile at iS minutes. However, in a recent report
Tielemans et al [26] have shown that cellular activation occurs
with both polyacrylonitrile and cuprophan, even though the
up-regulation of CD11b is lower and delayed with PAN in
comparison with CU. These data are in agreement with our
observations that synthetic membranes activate polyphospho-
inositide turnover later and to a lower degree than cuprophan.
Furthermore, it is noteworthy that in our system cellular activa-
tion is complement independent. Since the experiments on 32D
cells in serum-free medium, thus ruling out any possible involve-
ment of the complement system in activating cell signaling, gave
results qualitatively identical to those performed on human
leukocytes, we postulate that at least a conspicuous part of cellular
activation and DAG formation is related with adhesion to, and
contact with the membranes. Thus, although the involvement of
the complement system is clearly at work during actual dialysis, we
believe that the membranes per se have an effect on cell activation
and signal transduction, possibly by perturbing the plasma mem-
brane in such a way to cause the activation of enzymes involved in
signal transduction. Similarly, Cheung, Parker and Hohnholt [27]
have recently suggested that CDii!CD18 is an essential compo-
nent in cuprophan-induced neutrophil degranulation and that
both complement-dependent and complement-independent fac-
tors are involved. Complement-independent neutrophil degranu-
lation has been further confirmed by Bohler et al [28], who
speculate that granulocyte activation may be G-protein and
receptor dependent. We are not able to specify which component
of the cuprophan membrane is to be held responsible for cellular
activation. We cannot rule out a possible involvment of beta-
glucan in this stimulation, even though we rinsed the in vitro
system. However, it is more likely that this activation is due to
components present in cuprophan membranes such as L-fucose,
as recently suggested by Deppisch et al [29]. Future experiments
will clarify the role of the different membrane components in
activating transmembrane cell signaling.
In summary, we have demonstrated that renal disease does not
seem to impair the ability of hematopoietic cells to respond to
agonists. Different dialysis membranes directly stimulate cell
signaling to a different extent. Chronic intermittent perdialytic
dialyzer-induced cell stimulation may down-regulate surface re-
ceptor activities, "switching off" intracellular signaling systems,
preventing cells from responding to further natural stimuli. These
findings indicate that early alterations of transmembrane signaling
may play a role in leukocyte physiopathology during dialysis.
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